300 North Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q2 | – | Sell |
-4,417
| Closed | -$1.85M | – | 53 |
|
2015
Q1 | $1.85M | Buy |
4,417
+49
| +1% | +$20.5K | 0.41% | 89 |
|
2014
Q4 | $1.2M | Buy |
4,368
+1,633
| +60% | +$447K | 0.28% | 88 |
|
2014
Q3 | $533K | Hold |
2,735
| – | – | 0.14% | 96 |
|
2014
Q2 | $670K | Hold |
2,735
| – | – | 0.17% | 85 |
|
2014
Q1 | $725K | Buy |
2,735
+146
| +6% | +$38.7K | 0.19% | 85 |
|
2013
Q4 | $940K | Sell |
2,589
-200
| -7% | -$72.6K | 0.26% | 80 |
|
2013
Q3 | $1.48M | Buy |
+2,789
| New | +$1.48M | 0.35% | 93 |
|